ASCO GU Conference Coverage
Filter News By:
Featured Articles
(Medscape Medical News) Feb 17, 2020 - For the first time, a clear cell renal cell carcinoma therapy targets a molecular driver of the cancer that was previously believed to be "undruggable," said investigator Toni Choueiri, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, here at the Genitourinary Cancers Symposium (GUCS)...
Read Article
(MedPage Today) Feb 15, 2020 - Patients with cisplatin-ineligible advanced bladder cancer achieved durable objective responses with the combination of pembrolizumab (Keytruda) and a newly approved antibody-drug conjugate (ADC), new data from a phase I trial showed. Overall, 33 of 45 patients responded to pembrolizumab and enfortumab...
Read Article
Latest Articles
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
View More
News Commentary
There is no ASCO GU Conference Coverage commentary.

OBR Blog
There are no ASCO GU Conference Coverage blog entries.

OBR Tweets

Mar 30
H. Jack West, MD: This provides another option that is pretty much a lateral move compared to atezolizumab with che… https://t.co/hnkRD0AfXw

Mar 26
Howard S. Hochster, MD: There is no question that SARS-CoV-2 will prove to be a major challenge to all health care… https://t.co/EyJijktM68

Mar 25
OBR speaks to providers at community oncology practices like Florida Cancer Specialists & Research Institute (FCS)… https://t.co/3qyne3w9gE

Mar 25
Dr. David Penson of Vanderbilt University Medical Center @VUmedicine delves into Financial toxicity and its negativ… https://t.co/o2IUnKvcff

Mar 25
Dr. Azra Raza @AzraRazaMD, an Oncologist at @Columbia, speaks to us about her recently published book @thefirstcell… https://t.co/x1HmTvHta7

Mar 25
H. Jack West, MD: An excellent piece that highlights what the history of cancer research should be teaching the wor… https://t.co/QAEpZJP8ov

Mar 24
Preparing your Oncology Clinic for COVID-19 Infections - Webinar Archive Now Available https://t.co/CV2a4q4DUl ft.… https://t.co/KvibaK0WdL

Mar 18
H. Jack West, MD: The CASPIAN trial was positive for a survival benefit with durvalumab added to platinum/etoposide… https://t.co/gdMU91vjN1

Mar 16
William McGivney, PhD: I know that I quoted that health care policy sage, Yogi Berra, a few commentaries ago, but h… https://t.co/h1xFemYuf9

Mar 13
Melody Chang, RPh, MBA, BCOP, of Florida Cancer Specialists elaborates on 340B's affect on pharmacy operations at F… https://t.co/RcEJlDtAhw